DURECT Corp
NASDAQ:DRRX

Watchlist Manager
DURECT Corp Logo
DURECT Corp
NASDAQ:DRRX
Watchlist
Price: 1.26 USD -2.33% Market Closed
Market Cap: 39.1m USD
Have any thoughts about
DURECT Corp?
Write Note

DURECT Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DURECT Corp
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
DURECT Corp
NASDAQ:DRRX
Operating Income
-$24.9m
CAGR 3-Years
11%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.4B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$11.1B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Operating Income
$10.8B
CAGR 3-Years
-11%
CAGR 5-Years
23%
CAGR 10-Years
-4%
Merck & Co Inc
NYSE:MRK
Operating Income
$17.9B
CAGR 3-Years
21%
CAGR 5-Years
7%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Operating Income
$13.4B
CAGR 3-Years
25%
CAGR 5-Years
19%
CAGR 10-Years
12%

See Also

What is DURECT Corp's Operating Income?
Operating Income
-24.9m USD

Based on the financial report for Jun 30, 2024, DURECT Corp's Operating Income amounts to -24.9m USD.

What is DURECT Corp's Operating Income growth rate?
Operating Income CAGR 10Y
-2%

Over the last year, the Operating Income growth was 28%. The average annual Operating Income growth rates for DURECT Corp have been 11% over the past three years , -2% over the past five years , and -2% over the past ten years .

Back to Top